Nadja M. Meindl‐Beinker
- Hepatology top 5%
- Liver physiology and pathology 9
- Molecular Biology top 10%
- TGF-β signaling in diseases 5
- RNA and protein synthesis mechanisms 4
- Lipid Membrane Structure and Behavior 3
- Cell Biology top 10%
- Genetics top 10%
- Microbiology top 10%
-
- Esophageal Cancer Research and Treatment 5
-
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
Nadja M. Meindl‐Beinker
18 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 162
- Molecular Biology 899
- Cell Biology 169
- Genetics 223
- Microbiology 41
Countries citing papers authored by Nadja M. Meindl‐Beinker
This map shows the geographic impact of Nadja M. Meindl‐Beinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadja M. Meindl‐Beinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadja M. Meindl‐Beinker more than expected).
Fields of papers citing papers by Nadja M. Meindl‐Beinker
This network shows the impact of papers produced by Nadja M. Meindl‐Beinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadja M. Meindl‐Beinker. The network helps show where Nadja M. Meindl‐Beinker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nadja M. Meindl‐Beinker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 1 | |
| 8 | 2019 | 21 | |
| 9 | 2019 | 0 | |
| 10 | 2016 | 52 | |
| 11 | 2013 | 73 | |
| 12 | 2012 | 66 | |
| 13 | 2010 | 48 | |
| 14 | 2009 | 72 | |
| 15 | 2008 | 92 | |
| 16 | 2007 | 23 | |
| 17 | Molecular code for transmembrane-helix recognition by the Sec61 transloconbreakdown → | 2007 | 565 |
| 18 | 2006 | 67 | |
| 19 | 2005 | 111 | |
| 20 | 2005 | 38 |
About Nadja M. Meindl‐Beinker
Nadja M. Meindl‐Beinker is a scholar working on Hepatology, Oncology and Gastroenterology, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver physiology and pathology (9 papers), TGF-β signaling in diseases (5 papers), Esophageal Cancer Research and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), RNA and protein synthesis mechanisms (4 papers), Lipid Membrane Structure and Behavior (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Hepatology (162 citations), Molecular Biology (899 citations) and Cell Biology (169 citations). Nadja M. Meindl‐Beinker has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Steven Dooley, Stephen H. White, IngMarie Nilsson, Gunnar von Heijne, Yoko Sato, Hyun Kim, Tara Hessa, Andreas Bernsel, Koichi Matsuzaki and Carolina Lundin. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.